Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q



þ		QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2016



o		TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 001-36103

TECOGEN INC.

(Exact name of Registrant as specified in its charter)



Delaware	04-3536131
(State or Other Jurisdiction of Incorporation or Organization)	(IRS Employer Identification No.)



45 First Avenue
Waltham, Massachusetts	02451
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s Telephone Number, Including Area Code: (781) 622-1120

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months, (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ý No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:



Large accelerated filer o	Accelerated filer o
Non –accelerated filer o	Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes ¨ No ý



Title of each class		Outstanding, November 4, 2016
Common Stock, $0.001 par value		19,949,672

TECOGEN INC.

QUARTERLY REPORT ON FORM 10-Q

FOR THE PERIOD ENDED SEPTEMBER 30, 2016

TABLE OF CONTENTS



PART I - FINANCIAL INFORMATION

Item 1.	Financial Statements	1
	Condensed Consolidated Balance Sheets - September 30, 2016 and December 31, 2015 (unaudited)	1
	Condensed Consolidated Statements of Operations - three and nine months ended September 30, 2016 and 2015 (unaudited)	2
	Condensed Consolidated Statements of Cash Flows - nine months ended September 30, 2016 and 2015 (unaudited)	3
	Notes to Condensed Consolidated Financial Statements (unaudited)	4

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	10

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	13

Item 4.	Controls and Procedures	13

PART II - OTHER INFORMATION

Item 6.	Exhibits	14

Signatures		15

References in this Form 10-Q to "we", "us", "our"', the "Company" and "Tecogen" refers to Tecogen Inc. and its consolidated subsidiary, unless otherwise noted.

TECOGEN INC.

PART I - FINANCIAL INFORMATION

Item 1 - Financial Statements

CONDENSED CONSOLIDATED BALANCE SHEETS

As of September 30, 2016 and December 31, 2015

(unaudited)



	September 30, 2016			December 31, 2015
ASSETS
Current assets:
Cash and cash equivalents	$	3,502,057		$	5,486,526
Short-term investments	—			294,802
Accounts receivable, net	7,957,325			5,286,863
Unbilled revenue	2,096,667			1,072,391
Inventory, net	5,058,147			5,683,043
Due from related party	432,995			1,177,261
Prepaid and other current assets	453,503			353,105
Total current assets	19,500,694			19,353,991
Property, plant and equipment, net	548,357			543,754
Intangible assets, net	1,042,324			1,044,611
Goodwill	40,870			40,870
Investment in Ultra Emissions Technologies Limited	2,000,000			—
Other assets	58,425			58,425
TOTAL ASSETS	$	23,190,670		$	21,041,651

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	3,032,613		$	3,311,809
Accrued expenses	1,189,669			1,066,860
Deferred revenue	1,014,381			996,941
Total current liabilities	5,236,663			5,375,610
Long-term liabilities:
Deferred revenue, net of current portion	439,825			273,162
Senior convertible promissory note, related party	3,136,900			2,951,011
Total liabilities	8,813,388			8,599,783
Commitments and contingencies (Note 6)

Stockholders’ equity:
Tecogen Inc. stockholders’ equity:
Common stock, $0.001 par value; 100,000,000 shares authorized; 19,949,672 and 18,478,990 issued and outstanding at September 30, 2016 and December 31, 2015	19,950			18,479
Additional paid-in capital	37,205,570			34,501,640
Accumulated deficit	(22,848,238		)	(21,682,437		)
Total Tecogen Inc. stockholders’ equity	14,377,282			12,837,682
Noncontrolling interest	—			(395,814		)
Total stockholders’ equity	14,377,282			12,441,868
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	23,190,670		$	21,041,651

The accompanying notes are an integral part of these consolidated financial statements.

TECOGEN INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

For the three and nine months months ended September 30, 2016 and 2015

(unaudited)



	Three months ended September 30,						Nine months ended September 30,
	2016			2015			2016			2015
Revenues
Products	$	2,850,901		$	1,860,860		$	7,525,909		$	8,744,306
Services	3,765,554			2,815,182			9,853,369			8,419,001
Total revenues	6,616,455			4,676,042			17,379,278			17,163,307
Cost of sales
Products	1,715,462			1,262,480			5,035,230			6,040,533
Services	2,126,175			1,744,631			5,746,992			5,087,978
Total cost of sales	3,841,637			3,007,111			10,782,222			11,128,511
Gross profit	2,774,818			1,668,931			6,597,056			6,034,796
Operating expenses
General and administrative	2,003,838			1,864,529			5,898,230			5,942,161
Selling	367,412			521,924			1,217,533			1,339,982
Research and development	154,075			206,223			524,696			610,703
Total operating expenses	2,525,325			2,592,676			7,640,459			7,892,846
Income (loss) from operations	249,493			(923,745		)	(1,043,403		)	(1,858,050		)
Other income (expense)
Interest and other income	3,914			2,157			9,575			11,945
Interest expense	(45,539		)	(68,216		)	(131,973		)	(128,626		)
Total other expense, net	(41,625		)	(66,059		)	(122,398		)	(116,681		)
Income (loss) before income taxes	207,868			(989,804		)	(1,165,801		)	(1,974,731		)
Consolidated net income (loss)	207,868			(989,804		)	(1,165,801		)	(1,974,731		)
Less: Loss attributable to the noncontrolling interest	—			40,962			64,962			45,587
Net income (loss) attributable to Tecogen Inc.	$	207,868		$	(948,842	)	$	(1,100,839	)	$	(1,929,144	)
Net income (loss) per share - basic	$	0.01		$	(0.06	)	$	(0.06	)	$	(0.12	)
Net income (loss) per share - diluted	$	0.01		$	(0.06	)	$	(0.06	)	$	(0.12	)
Weighted average shares outstanding - basic	19,640,812			17,153,999			19,071,497			16,575,879
Weighted average shares outstanding - diluted	20,229,120			17,153,999			19,071,497			16,575,879

The accompanying notes are an integral part of these consolidated financial statements.

TECOGEN INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the nine months ended September 30, 2016 and 2015

(unaudited)



	September 30,
	2016			2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Consolidated net loss	$	(1,165,801	)	$	(1,974,731	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	198,766			205,262
Change in provision for allowance on accounts receivable	(6,000		)	—
Provision (recovery) for inventory reserve	(90,000		)	(25,000		)
Stock-based compensation	117,065			90,971
Non-cash interest expense	37,923			37,550
Loss (gain) on sale of assets	640			(4,631		)
Short term investments	294,802			290,974
Changes in operating assets and liabilities
(Increase) decrease in:
Accounts receivable	(2,664,462		)	419,256
Unbilled revenue	(1,024,276		)	(1,104,143		)
Inventory, net	714,896			(584,692		)
Due from related party	744,266			(348,878		)
Prepaid expenses and other current assets	(100,398		)	(5,991		)
Other non-current assets	—			(5,100		)
Increase (decrease) in:
Accounts payable	(279,196		)	425,545
Accrued expenses	122,809			130,761
Deferred revenue	184,103			(901,872		)
Net cash used in operating activities	(2,914,863		)	(3,354,719		)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(130,499		)	(48,827		)
Proceeds from sale of assets	—			16,874
Purchases of intangible assets	(71,223		)	(110,502		)
Cash paid for investment in Ultra Emissions Technologies Ltd	(2,000,000		)	—
Net cash used in investing activities	(2,201,722		)	(142,455		)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payment of debt issuance costs	(2,034		)	—
Proceeds on demand notes payable	150,000			—
Payment of stock issuance costs	(28,548		)	—
Proceeds from sale of restricted common stock, net	—			5,920,927
Proceeds from the exercise of stock options	312,698			360,225
Proceeds from the exercise of warrants	2,700,000			—
Net cash provided by financing activities	3,132,116			6,281,152
Net increase (decrease) in cash and cash equivalents	(1,984,469		)	2,783,978
Cash and cash equivalents, beginning of the period	5,486,526			1,186,033
Cash and cash equivalents, end of the period	$	3,502,057		$	3,970,011
Supplemental disclosures of cash flows information:
Cash paid for interest	$	94,049		$	91,076
Stock exchange for non-controlling interest in Ilios	330,852			—

The accompanying notes are an integral part of these consolidated financial statements.

TECOGEN INC.

Notes to Interim Unaudited Condensed Consolidated Financial Statements for the three and nine months ended September 30, 2016 and 2015

Note 1 – Description of business and summary of significant accounting policies

Description of business

Tecogen Inc., or the Company, was organized as a Delaware Corporation on November 15, 2000, and acquired the assets and liabilities of the Tecogen Products division of Thermo Power Corporation. The Company produces commercial and industrial, natural-gas-fueled engine-driven, combined heat and power (CHP) products that reduce energy costs, decrease greenhouse gas emissions and alleviate congestion on the national power grid. The Company’s products supply electric power or mechanical power for cooling, while heat from the engine is recovered and purposefully used at a facility. The majority of the Company’s customers are located in regions with the highest utility rates, typically California, the Midwest and the Northeast. The Company's common stock is listed on the NASDAQ under the ticker symbol TGEN.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions for Form 10-Q and therefore do not include all information and notes necessary for a complete presentation of our financial position, results of operations and cash flows, in conformity with generally accepted accounting principles. We filed audited financial statements which included all information and notes necessary for such presentation for the two years ended December 31, 2015 in conjunction with our 2015 Annual Report on Form 10-K, or our Annual Report, filed with the Securities and Exchange Commission, or SEC, on March 30, 2016. This form 10-Q should be read in conjunction with our Annual Report.

The accompanying unaudited condensed consolidated balance sheets, statements of operations and statements of cash flows reflect all adjustments (consisting only of normal recurring items) which are, in the opinion of management, necessary for a fair presentation of financial position at September 30, 2016, and of operations and cash flows for the interim periods ended September 30, 2016 and 2015. The results of operations for the interim periods ended September 30, 2016 are not necessarily indicative of the results to be expected for the year.

The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary Ilios Inc. or Ilios, whose business focus is on advanced heating systems for commercial and industrial applications. In May 2016, the Company completed an exchange of common stock with the shareholders of Ilios and effected a statutory merger. Ilios is no longer a separate subsidiary.

The Company’s operations are comprised of one business segment. Our business is to manufacture and support highly efficient CHP products based on engines fueled by natural gas.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Revenue Recognition

Revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. Generally, sales of cogeneration and chiller units and parts are recognized when shipped and services are recognized over the term of the service period. Payments received in advance of services being performed or as a deposit on equipment are recorded as deferred revenue.

The Company recognizes revenue in certain circumstances before delivery has occurred (commonly referred to as bill and hold transactions). In such circumstances, among other things, risk of ownership has passed to the buyer, the buyer has made a written fixed commitment to purchase the finished goods, the buyer has requested the finished goods be held for future delivery as scheduled and designated by them, and no additional performance obligations exist by the Company. For these transactions, the finished goods are segregated from inventory and normal billing and credit terms are granted. At the period ended September 30, 2016, revenues of $1,548,422 were recorded as bill and hold transactions. For the same period in 2015, $747,328 revenues were recorded as bill and hold transactions.

For those arrangements that include multiple deliverables, the Company first determines whether each service or deliverable meets the separation criteria of FASB ASC 605-25, Revenue Recognition—Multiple-Element Arrangements. In general, a deliverable (or a group of deliverables) meets the separation criteria if the deliverable has stand-alone value to the customer and if the arrangement includes a general right of return related to the delivered item and delivery or performance of the undelivered item(s) is considered probable and substantially in control of the Company. Each deliverable that meets the separation criteria is considered a separate ‘‘unit of accounting”. The Company allocates the total arrangement consideration to each unit of accounting

TECOGEN INC.

Notes to Interim Unaudited Condensed Consolidated Financial Statements for the three and nine months ended September 30, 2016 and 2015

using the relative fair value method. The amount of arrangement consideration that is allocated to a delivered unit of accounting is limited to the amount that is not contingent upon the delivery of another unit of accounting.

When vendor-specific objective evidence or third-party evidence is not available, adopting the relative fair value method of allocation permits the Company to recognize revenue on specific elements as completed based on the estimated selling price. The Company generally uses internal pricing lists that determine sales prices to external customers in determining its best estimate of the selling price of the various deliverables in multiple-element arrangements. Changes in judgments made in estimating the selling price of the various deliverables could significantly affect the timing or amount of revenue recognition. The Company enters into sales arrangements with customers to sell its cogeneration and chiller units and related service contracts and occasionally installation services. Based on the fact that the Company sells each deliverable to other customers on a stand-alone basis, the Company has determined that each deliverable has a stand-alone value. Additionally, there are no rights of return relative to the delivered items; therefore, each deliverable is considered a separate unit of accounting.

After the arrangement consideration has been allocated to each unit of accounting, the Company applies the appropriate revenue recognition method for each unit of accounting based on the nature of the arrangement and the services included in each unit of accounting. Cogeneration and chiller units are recognized when shipped and services are recognized over the term of the applicable agreement, or as provided when on a time and materials basis.

In some cases, our customers may choose to have the Company engineer and install the system for them rather than simply purchase the cogeneration and/or chiller units. In this case, the Company accounts for revenue, or turnkey revenue, and costs using the percentage-of-completion method of accounting. Under the percentage-of-completion method of accounting, revenues are recognized by applying percentages of completion to the total estimated revenues for the respective contracts. Costs are recognized as incurred. The percentages of completion are determined by relating the actual cost of work performed to date to the current estimated total cost at completion of the respective contracts. When the estimate on a contract indicates a loss, the Company’s policy is to record the entire expected loss, regardless of the percentage of completion. During the nine months ended September 30, 2016 and 2015, a loss of approximately $164,000 and $0, respectively was recorded. The excess of contract costs and profit recognized to date on the percentage-of-completion accounting method in excess of billings is recorded as unbilled revenue. Billings in excess of related costs and estimated profit is recorded as deferred revenue.

Accounts Receivable

Accounts receivable are stated at the amount management expects to collect from outstanding balances. An allowance for doubtful accounts is provided for those accounts receivable considered to be uncollectible based upon historical experience and management’s evaluation of outstanding accounts receivable at the end of the period. Bad debts are written off against the allowance when identified. At September 30, 2016 and December 31, 2015 the allowance for doubtful accounts was approximately $44,000 and $50,000, respectively.

Inventory

Raw materials, work in process, and finished goods inventories are stated at the lower of cost, as determined by the average cost method, or net realizable value. The Company periodically reviews inventory quantities on hand for excess and/or obsolete inventory based primarily on historical usage, as well as based on estimated forecast of product demand. Any reserves that result from this review are charged to cost of sales. At September 30, 2016 and December 31, 2015, inventory reserves were $203,000 and $293,000, respectively.

Property, Plant and Equipment

Property, plant and equipment are recorded at cost. Depreciation is provided using the straight-line method over the estimated useful lives of the asset, which range from three to fifteen years. Leasehold improvements are amortized using the straight-line method over the lesser of the estimated useful lives of the assets or the term of the related leases. Expenditures for maintenance and repairs are expensed currently, while renewals and betterments that materially extend the life of an asset are capitalized. For the three and nine months ended September 30, 2016 and 2015, depreciation expense was $42,084 and $42,366, and $125,255 and $129,775, respectively.

Intangible Assets

Intangible assets are amortized on a straight-line basis over the estimated economic life of the intangible asset. The Company reviews intangible assets for impairment when the circumstances warrant.

Goodwill

The Company tests its recorded goodwill for impairment in the fourth quarter, or more often if indicators of potential impairment exist, by determining if the carrying value of the Company's single reporting unit exceeds its estimated fair value. During the first nine months of 2016, the Company determined that no interim impairment test was necessary.

TECOGEN INC.

Notes to Interim Unaudited Condensed Consolidated Financial Statements for the three and nine months ended September 30, 2016 and 2015

Stock-Based Compensation

Stock-based compensation cost is measured at the grant date based on the estimated fair value of the award and is recognized as an expense in the consolidated statements of operations over the requisite service period. The fair value of stock options granted is estimated using the Black-Scholes option pricing valuation model. The Company recognizes compensation on a straight-line basis for each separately vesting portion of the option award. The determination of the fair value of share-based payment awards is affected by the Company’s stock price. The Company uses the simplified method for awards of stock-based compensation since it does not have the necessary historical exercise and forfeiture data to determine an expected life for stock options. (see Note 5)

Revenues by Product

The following table summarizes net revenue by product line and services for the three and nine months ended September 30, 2016 and 2015:



	Three months ended September 30,				Nine months ended September 30,
	2016		2015		2016		2015
Products
Cogeneration	$	2,639,713	$	1,493,335	$	5,328,184	$	6,592,075
Chiller & Heat Pump	211,188		367,525		2,197,725		2,152,231
Total Product Revenue	2,850,901		1,860,860		7,525,909		8,744,306
Services
Service contracts	2,113,295		1,921,897		6,384,261		5,829,304
Installations	1,652,259		893,285		3,469,108		2,589,697
Total Service Revenue	3,765,554		2,815,182		9,853,369		8,419,001
Total Revenue	$	6,616,455	$	4,676,042	$	17,379,278	$	17,163,307

Reclassification

Certain prior period balances have been reclassified to conform with current period presentation. The interest expense includes the amortization of the deferred financing costs, and this has been adjusted in the comparable periods. The balance of deferred financing cost on the balance sheet under ASU 2015-03 is netted with the associated debt and is retrospectively shown for prior period balances.

Note 2 – Income (Loss) per common share

All shares issuable for both periods were anti-dilutive because of the reported net loss. Basic and diluted loss per share for the three months ended September 30, 2016 and 2015, and nine months ended September 30, 2016 and 2015, respectively, were as follows:



	Three months ended September 30,					Nine months ended September 30,
	2016		2015			2016			2015
Net income (loss) attributable to stockholders	$	207,868	$	(948,842	)	$	(1,100,839	)	$	(1,929,144	)
Weighted average shares outstanding - Basic	19,640,812		17,153,999			19,071,497			16,575,879
Basic income (loss) per share	$	0.01	$	(0.06	)	$	(0.06	)	$	(0.12	)
Weighted average shares outstanding - Diluted	20,229,120		17,153,999			19,071,497			16,575,879
Diluted income (loss) per share	$	0.01	$	(0.06	)	$	(0.06	)	$	(0.12	)
Anti-dilutive shares underlying stock options outstanding			1,186,325			1,130,158			1,186,325
Anti-dilutive convertible debentures			625,000			889,830			625,000
Anti-dilutive warrants outstanding			—			250,000			—

TECOGEN INC.

Notes to Interim Unaudited Condensed Consolidated Financial Statements for the three and nine months ended September 30, 2016 and 2015

Note 3 – Demand notes payable, convertible debentures and line of credit agreement to related parties

On December 23, 2013, the Company entered into a Senior Convertible Promissory Note or the Note, with Michaelson Capital Special Finance Fund LP or Michaelson, for the principal amount of $3,000,000 with interest at 4% per annum for a term of three years. In the event of default such interest rate shall accrue at 8% after the occurrence of the event of default and during continuance plus 2% after the occurrence and during the continuance of any other event of default. The Note is a senior unsecured obligation which pays interest only on a monthly basis in arrears at a rate of 4% per annum, unless earlier converted in accordance with the terms of the agreement prior to such date. Effective April 1, 2016, the Note was amended increasing the principal amount by $150,000 for a total of $3,150,000 and extending the maturity date. The principal amount, if not converted, is now due on the fifth anniversary of the Note, December 28, 2018. The Note is senior in right of payment to any unsecured indebtedness that is expressly subordinated in right of payment to the Note.

The principal balance of the Note, together with any unpaid interest, is convertible into shares of the Company's common stock at 282.49 shares of the Company's common stock per $1,000 principal amount of Note (equivalent to a conversion price of $3.54 per share) at the option of Michaelson. If at any time the common stock of the Company is (1) trading on a national securities exchange, (2) qualifies for unrestricted resale under federal securities laws and (3) the arithmetic average of the volume weighted average price of the Common Stock for twenty consecutive trading days preceding the Company's notice of mandatory conversion exceeds $150,000, the Company shall have the right to require conversion of all of the then outstanding principal balance together with unpaid interest of this Note into the Company's common stock based on the conversion price of $3.54 per share. The Company may prepay all of the outstanding principal and interest due and payable under this Note in full, at any time prior to the maturity date for an amount equal to 120% of the then outstanding principal and interest due and payable as of the date of such prepayment.

Upon change of control, as defined by the Note, at Michaelson's option, the obligations may be assumed, on the terms and conditions in this Note, through an assignment and assumption agreement, or the Company may prepay all of the then outstanding principal and unpaid interest under this Note in full at the optional 120% prepayment amount. This provision creates an embedded derivative in accordance with FASB ASC 815, Derivatives and Hedging. As such it is required to be bifurcated and accounted for separately from the Note. However, the Company has determined that the fair value of the embedded derivative is immaterial to the consolidated financial statements. Debt issuance costs are netted against the principal balance of the debt.

As per an amendment to the Note dated April 1, 2016, the conversion price was increased from $3.37 to $3.54 and the number of shares issuable upon conversion decreased from 890,207 at December 31, 2015 to 889,830 at April 1, 2016. The Company has determined that changes resulting from this modification were immaterial to the consolidated financial statements.

On June 15, 2015, the Company entered into a Non-Revolving Line of Credit Agreement, or the Agreement, with John N. Hatsopoulos, the Company's Co-Chief Executive Officer and a Company Director. Under the terms of the Agreement, Mr. Hatsopoulos has agreed to lend the Company up to an aggregate of $2,000,000, with a withdrawal limit of $250,000 per financial calendar quarter, at the written request of the Company. Any amounts borrowed by the Company pursuant to the Agreement will bear interest at 6% per year. Interest is due and payable quarterly in arrears. The term of the Agreement is from July 1, 2015 to July 1, 2017. Repayment of the principal amount borrowed pursuant to the Agreement will be due on July 1, 2017, or the Maturity Date. Prepayment of any amounts due under the Agreement may be made at any time without penalty. The Agreement terminates on the Maturity Date. The Company has not yet borrowed any amounts pursuant to the Agreement.

Note 4 - Stockholders' Equity and Ilios subsidiary

Beginning on April 11, 2016 through its conclusion on May 3, 2016, the Company entered into numerous private placement share exchange agreements ("Share Exchange Agreements") with shareholders of Ilios ("Exchanging Shareholders"), a majority owned subsidiary of the Company. Pursuant to the Share Exchange Agreements, the Exchanging Shareholders agreed to exchange every 7.86 of their restricted Ilios shares of common stock for 1 share of the Company's restricted common stock. In addition, the Company granted each Exchanging Shareholder registration rights of the Company's common stock they received in exchange for their Ilios shares. The Company issued a total of 670,464 shares of its common stock in exchange for Ilios shares of common stock. Pursuant to the Registration Rights Agreement, the Company filed a registration statement covering the resale of the shares.

Upon execution of the exchange agreements for 100% of the shares of Ilios, the Company no longer had a non-controlling interest in its subsidiary. On April 30, 2016, Ilios was merged into the Company, and accounting for the noncontrolling interest in the subsidiary ended.

Note 5 - Stock-based compensation

Stock-Based Compensation

In 2006, the Company adopted the 2006 Stock Option and Incentive Plan or the Plan, under which the Board of Directors may grant incentive or non-qualified stock options and stock grants to key employees, directors, advisors and consultants of the Company. The Plan was amended at various dates by the Board of Directors to increase the reserved shares of common stock issuable under the Plan to 3,838,750 as of September 30, 2016, or the Amended Plan.

TECOGEN INC.

Notes to Interim Unaudited Condensed Consolidated Financial Statements for the three and nine months ended September 30, 2016 and 2015

Stock options vest based upon the terms within the individual option grants, with an acceleration of the unvested portion of such options upon a change in control event, as defined in the Amended Plan. The options are not transferable except by will or domestic relations order. The option price per share under the Amended Plan cannot be less than the fair market value of the underlying shares on the date of the grant. The number of shares remaining available for future issuance under the Amended Plan as of September 30, 2016 was 1,627,357.

Stock option activity for the nine months ended September 30, 2016 was as follows:



Common Stock Options	Number of Options		Exercise Price Per Share	Weighted Average Exercise Price		Weighted Average Remaining Life	Aggregate Intrinsic Value
Outstanding, December 31, 2015	1,268,200		$1.20-$5.39	$	3.06	6.01 years	$	985,578
Granted	187,701		$0.79-$4.27	3.47
Exercised	(125,218	)	$1.20-$2.60	2.50
Canceled and forfeited	(200,525	)	$3.39-$4.96	3.73
Expired	—		—	—
Outstanding, September 30, 2016	1,130,158		$0.79-$5.39	$	3.07	5.32 years	$	1,432,957
Exercisable, September 30, 2016	821,658			$	2.51		$	1,417,032
Vested and expected to vest, September 30, 2016	1,083,883			$	3.01		$	1,430,569

Consolidated stock-based compensation expense for the nine months ended September 30, 2016 and 2015 was $117,065 and $90,971, respectively. No tax benefit was recognized related to the stock-based compensation recorded during the periods.

Note 6 – Commitments and contingencies

Letters of Credit

On January 28, 2016, the letter of credit from Enterprise Bank and Trust Company required for collateral with an outstanding performance bond was closed as the Company had met the performance obligations of the bond.

Note 7 – Related party transactions and Joint Ventures

The Company has two affiliated companies, namely American DG Energy Inc., or American DG Energy, and EuroSite Power Inc. or EuroSite Power. These companies are affiliates because several of the major stockholders of those companies, have a significant ownership position in the Company. Neither American DG Energy nor EuroSite Power own any shares of the Company, and the Company does not own any shares of American DG Energy or EuroSite Power.

On December 23, 2013, the Company entered into a Senior Convertible Promissory Note with Michaelson Capital Special Finance Fund LP (see Note 3). This agreement came with board observation rights causing the related party status.

On June 15, 2015, the Company entered into a Non-Revolving Line of Credit Agreement with John N. Hatsopoulos, the Company's Co-Chief Executive Officer and a Company Director (see Note 3).

The Company provides office space and certain utilities to American DG Energy based on a monthly rate set at the beginning of each year. This sublease was signed on July 1, 2014 and subsequently amended. The lease will expire on July 1, 2017. The agreement contains an automatic monthly renewal at expiration. In addition, the Company pays certain operating expenses, including benefits and insurance, on behalf of American DG Energy. The Company is reimbursed for these costs.

Ultra Emissions Technologies Ltd.

On December 28, 2015, the Company entered into a joint venture agreement relating to the formation of a joint venture company (the “JV”) organized to develop and commercialize Tecogen’s patented technology (“Ultera^® Technology”) designed to reduce harmful emissions generated by engines using fossil fuels. The joint venture company, called Ultra Emissions Technologies Limited, was organized under the laws of the Island of Jersey, Channel Islands.

The Company received a 50% equity interest in the JV in exchange for a fully paid-up worldwide license to use Tecogen’s Ultera emissions control technology in the field of mobile vehicles burning fossil fuels. The other half of the joint venture equity interests were purchased for $3,000,000 by a small group of offshore investors. Warrants to purchase additional equity securities in the JV were granted to all parties pro rata. If the venture is not successful, all licensed intellectual property rights will revert to Tecogen.

TECOGEN INC.

Notes to Interim Unaudited Condensed Consolidated Financial Statements for the three and nine months ended September 30, 2016 and 2015

The JV is expected to have losses as it performs the necessary research and development with the Ultera technology. On August 2, 2016, Tecogen exercised 2,000,000 warrants (the "Ultratek Warrants"), in the JV, at $1.00 per share, for an aggregate amount of $2 million. The funds used to exercise the Ultratek Warrants were acquired by the Company from the holders of certain Company warrants (the "Tecogen Warrant Holders"), when they partially exercised their Tecogen warrants (the "Tecogen Warrants"), in July of 2016. The Tecogen Warrant Holders exercised a total of 675,000 Tecogen Warrants with a $4.00 exercise price, resulting in cash proceeds of $2,700,000 to the Company, which the Company then used some of the proceeds to invest in the JV. An additional $6,500,000 was raised from other outside investors for a total equity investment to date of $13,500,000. Due to this additional capital raise, Tecogen's ownership has decreased to 43%.

The Company is accounting for its interest in the JV using the equity method. Income and losses will be recorded consistent with an agreement between the JV shareholders as to how income and losses will be allocated. These allocations are consistent with the allocation of cash distributions and liquidating distributions of the JV. The shareholder agreement calls for Tecogen's investment to be returned before any other shareholder if the venture does not achieve commercialization. As a result, as of September 30, 2016, Tecogen has not recorded any of the income or losses of the JV.

TTcogen LLC

On May 19, 2016, the Company along with Tedom a.s., a corporation incorporated in the Czech Republic and a European combined heat and power product manufacturer, ("Tedom") entered into a joint venture, where the Company will hold a 50% participating interest and the remaining 50% interest will be with Tedom. As part of the joint venture, the parties agreed to create a Delaware limited liability company, TTcogen LLC ("TTcogen"), to carry out the business of the venture. Tedom granted TTcogen the sole and exclusive right to market, sell, offer for sale, and distribute certain products as agreed to by the parties throughout the United States. The product offerings of the joint venture expand the current Tecogen product offerings to the MicroCHP of 35kW to large 4,000kW plants. Tecogen agreed to refer all appropriate sale leads to TTcogen regarding the products agreed to by the parties and Tecogen shall have the first right to repair and maintain the products sold by TTcogen.

The TTcogen operations will be accounted for using equity method accounting. Any losses on the initial operation of the entity will not be consolidated in Tecogen's financial statements. Since Tecogen does not guarantee obligations of TTcogen, losses or liabilities of the joint venture are not recorded on the Company's financial statements. Using equity method accounting, as the venture becomes profitable with the expected growth, realized gains from profits will be added to the an investment asset account on the consolidated balance sheet.

Note 8 - Intangible assets other than goodwill

As of December 31, 2015 and September 30, 2016 the Company has the following amounts related to intangible assets:



	Product Certifications			Patents			Developed Technology			Trademarks		Total
Balance at December 31, 2015
Intangible assets	$	514,616		$	603,915		$	240,000		$	4,775	$	1,363,306
Less - accumulated amortization	(182,931		)	(91,764		)	(44,000		)	—		(318,695		)
	$	331,685		$	512,151		$	196,000		$	4,775	$	1,044,611

Balance at September 30, 2016
Intangible assets	$	520,117		$	659,473		240,000			$	14,940	$	1,434,530
Less - accumulated amortization	(221,184		)	(115,022		)	(56,000		)	—		(392,206		)
	$	298,933		$	544,451		$	184,000		$	14,940	$	1,042,324

The aggregate amortization expense of the Company's intangible assets for the three and nine months ended September 30, 2016 and 2015 was $24,741 and $24,067 and $73,511 and $75,487, respectively.

Note 9 - Subsequent events

On November 1, 2016, the Company entered into an agreement and plan of merger, dated as of November 1, 2016 with American DG Energy (NYSE MKT: ADGE) ("American DG"), and Tecogen.ADGE Acquisition Corp Inc., a Delaware corporation and a wholly-owned subsidiary of Tecogen ("Merger Subsidiary").

TECOGEN INC.

Notes to Interim Unaudited Condensed Consolidated Financial Statements for the three and nine months ended September 30, 2016 and 2015

Under the terms of the Merger Agreement, Merger Subsidiary will merge with and into American DG, with American DG becoming a wholly-owned subsidiary of Tecogen and the surviving corporation of the transaction (the "Merger"). The Merger is intended to qualify for federal income tax purposes as a tax-free reorganization under the provisions of Section 368(a) of the Internal Revenue Code of 1986. Subject to the terms and conditions of the Merger Agreement and shareholder approval, at the closing of the Merger, each outstanding share of American DG common stock will be converted into the right to receive approximately 0.092 shares of common stock of Tecogen ("the Exchange Ratio"). Consummation of the Merger is subject to customary closing conditions, including, among other things, approval by the stockholders of Tecogen and American DG. The Merger Agreement does not contain any termination, prohibitions on termination, no-shop clause, or reimbursements of Merger related expenses. As part of the Merger Agreement, American DG and Tecogen have made customary mutual representations and warranties.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Forward-looking statements are made throughout this Management’s Discussion and Analysis of Financial Condition and Results of Operations. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words “believes,” “anticipates,” “plans,” “expects,” “seeks,” “estimates” and similar expressions are intended to identify forward-looking statements. Such forward-looking statements include, among other things, statements regarding our current and future cash requirements, our expectations regarding suppliers of cogeneration units, and statements regarding potential financing activities in the future. While the Company may elect to update forward-looking statements in the future, it specifically disclaims any obligation to do so, even if the Company’s estimates change, and readers should not rely on those forward-looking statements as representing the Company’s views as of any date subsequent to the date of the filing of this Quarterly Report. There are a number of important factors that could cause the actual results of the Company to differ materially from those indicated by such forward-looking statements, including those detailed under the heading “Risk Factors” in this Quarterly Report.

Overview

Tecogen Inc., or the Company, or Tecogen, designs, manufactures and sells industrial and commercial cogeneration systems that produce combinations of electricity, hot water and air conditioning using automotive engines that have been specially adapted to run on natural gas. In some cases, our customers may choose to have the Company engineer and install the system for them rather than simply purchase the cogeneration and/or chiller units, which we refer to as "turnkey" projects. Cogeneration systems are efficient because in addition to supplying mechanical energy to power electric generators or compressors – displacing utility supplied electricity – they provide opportunity for the facility to incorporate the engine’s waste heat into onsite processes such as space and portable water heating. We produce standardized, modular, small-scale products, with a limited number of product configurations that are adaptable to multiple applications. We refer to these combined heat and power products as CHP (electricity plus heat) and MCHP (mechanical power plus heat).

In addition to being a smaller reporting company, Tecogen is an emerging growth company as that term is defined in the Jumpstart Our Business Startups Act of 2012 (JOBS Act).

Results of Operations

Revenues

Revenues in the third quarter of 2016 were $6,616,455 compared to $4,676,042 for the same period in 2015, an increase of $1,940,413 or 41.5%. Product revenues in the third quarter of 2016 were $2,850,901 compared to $1,860,860 for the same period in 2015, an increase of $990,041 or 53.2%. This increase was the aggregate of an increase in cogeneration sales of $1,146,378 and a decrease in chiller and heat pump sales, which include the Ilios products, of $156,337. Service revenues in the third quarter of 2016 were $3,765,554 compared to $2,815,182 for the same period in 2015, an increase of $950,372 or 33.8%. This increase in the third quarter is the due to an increase in installation activity of $758,974 and an increase of $191,398 in service contract revenues.

Revenues in the first nine months of 2016 were $17,379,278 compared to $17,163,307 for the same period in 2015, an increase of $215,971 or 1.3%. Product revenues in the first nine months of 2016 were $7,525,909 compared to $8,744,306 for the same period in 2015, a decrease of $1,218,397 or 13.9%. This decrease was the aggregate of a decrease in cogeneration sales of $1,263,891 and an increase in chiller and heat pump sales of $45,494. Service revenues in the first nine months of 2016 were $9,853,369 compared to $8,419,001 for the same period in 2015, an increase of $1,434,368 or 17.0%. This increase in the first nine months of 2016 is due to an increase in installation activity of $879,411 and an increase of $554,957 in the service contracts.

Table of Contents

TECOGEN INC.

Cost of Sales

Cost of sales in the third quarter of 2016 was $3,841,637 compared to $3,007,111 for the same period in 2015, an increase of $834,526, or 27.8%. During the third quarter of 2016 our overall gross profit margin was 41.9% compared to 35.7% for the same period in 2015, an increase of 17.4%. The increase in margins was the direct result of product upgrades and improvements. Management expects growth in sales volume to maintain this gross margin going forward.

Cost of sales in the first nine months of 2016 was $10,782,222 compared to $11,128,511 for the same period in 2015 a decrease of $346,289, or 3.1%. During the first nine months of 2016 our overall gross profit margin was 38.0% compared to 35.2% for the same period in 2015, an increase of 8.0%. The increase in margins was the direct result of product upgrades and improvements which were phased in over the first nine months. Management expects growth in sales volume to continue to improve gross margins going forward as lower margin quarters roll off the trailing period results.

Operating Expenses

General and administrative expenses consist of executive staff, accounting and legal expenses, office space, general insurance and other administrative expenses. General and administrative expenses in the third quarter ending September 30, 2016 were $2,003,838 compared to $1,864,529 for the same period in 2015, an increase of $139,309 or 7.5%. The majority of the increase was for the mergers and acquisition activities over the same period this year.

General and administrative expenses in the first nine months of 2016 were $5,898,230 compared to $5,942,161 for the same period in 2015, a decrease of $43,931 or 0.7%. This decrease is the result of managements continued efforts to contain and reduce our administrative expenses.

Selling expenses consist of sales staff, commissions, marketing, travel and other selling related expenses. Selling expenses for the third quarter of 2016 were $367,412 compared to $521,924 for the same period in 2015, a decrease of $154,512 or 29.6%. This difference is due to a higher mix of in-house sales versus representation commissions and lowered public relations fees.

Selling expenses for the first nine months of 2016 were $1,217,533 compared to $1,339,982 for the same period in 2015, a decrease of $122,449 or 9.1%. This difference is due to a higher mix of in-house sales versus representation commissions and lowered public relations fees.

Research and development expenses consist of engineering and technical staff, materials, outside consulting and other related expenses. Research and development expenses in the third quarter ending September 30, 2016 were $154,075 compared to $206,223 for the same period in 2015, a decrease of $52,148 or 25.3%. This decrease was due to the completion of a product development cycle.

Research and development expenses for the first nine months of 2016 were $524,696 compared to $610,703 for the same period in 2015, a decrease of $86,007 or 14.1%. This decrease was due to the timing of the completion of projects including product improvement programs.

Income (Loss) from Operations

Income from operations for the third quarter of 2016 was $249,493 compared to a loss of $923,745 for the same period in 2015, an increase of $1,173,238. The increase was due to a reduction in cost of goods sold and increased revenues from high margin products and services.

Loss from operations for the first nine months of 2016 was $1,043,403 compared to $1,858,050 for the same period in 2015, a decrease in loss of $814,647. The decrease in the loss was due to a reduction in cost of goods sold and continued expense reduction.

Other Income (Expense), net

Other expense, net for the three months ended September 30, 2016 was $41,625 compared to $66,059 for the same period in 2015. Other income (expense) includes interest income and other income of $3,914, net of interest expense on notes payable of $45,539 for the third quarter of 2016. For the same period in 2015, interest and other income was $2,157 and interest expense was $68,216.

Other expense, net for the nine months ended September 30, 2016 was $122,398 compared to $116,681 for the same period in 2015. Other income (expense) includes interest income and other income of $9,575, net of interest expense on notes payable of $131,973 for the first nine months of 2016. For the same period in 2015, interest and other income was $11,945 and interest expense was $128,626.

Table of Contents

TECOGEN INC.

Provision for Income Taxes

The Company did not record any benefit or provision for income taxes for the three and nine months ended September 30, 2016 and 2015, respectively. As of September 30, 2016 and 2015, the income tax benefits generated from the Company’s net losses have been fully reserved.

Noncontrolling Interest

The loss attributable to the noncontrolling interest was $0 in the three months ended September 30, 2016 as a result of the Company's acquisition of the noncontrolling interest in May 2016. For the same period in 2015, the loss attributable to the noncontrolling interest was $40,962.

The loss attributable to the noncontrolling interest was $64,962 in the nine months ended September 30, 2016. With the Company's acquisition of the noncontrolling interest in May 2016, this loss will remain unchanged through the end of 2016. For the same period in 2015, the loss attributable to the noncontrolling interest was $45,587.

Net Income (Loss)

Net income attributable to Tecogen for the three months ended September 30, 2016 was $207,868 compared to a loss of $948,842 for the same period in 2015, an increase of $1,156,710. The increase in income was the result of the reduction of cost of goods sold and higher margin product sales.

Net loss attributable to Tecogen for the nine months ended September 30, 2016 was $1,100,839 compared to $1,929,144 for the same period in 2015, a decrease of $828,305. The decrease in net loss was the result of the improvements in gross profit and higher revenues.

Liquidity and Capital Resources

Consolidated working capital at September 30, 2016 was $14,264,031 compared to $13,978,381 at December 31, 2015, an increase of $285,650. Included in working capital were cash and cash equivalents of $3,502,057 and $0 in short-term investments at September 30, 2016, compared to $5,486,526 in cash and cash equivalents and $294,802 in short-term investments at December 31, 2015, a decrease of $2,279,271. The increase in working capital and decrease in cash was the net of a reduced loss in the period and proceeds from equity transactions.

Cash used in operating activities for the nine months ended September 30, 2016 was $2,914,863 compared to $3,354,719 for the same period in 2015. Our accounts receivable balance increased to $7,957,325 at September 30, 2016 compared to $5,286,863 at December 31, 2015, using $2,664,462 of cash due to timing of billing, shipments, and collections. In addition, amounts due from related parties decreased by $744,266 providing cash due to timing of billing and collections. Our inventory decreased to $5,058,147 as of September 30, 2016 compared to $5,683,043 as of December 31, 2015, a decrease of $624,896. Although lowering inventory is a goal, management expects inventory to vary significantly based on production and customer delivery requirements.

As of September 30, 2016, the Company's backlog of product and installation projects, excluding service contracts, was $12 million, consisting of $4 million of purchase orders received by us and $8 million of projects in which the customer's internal approval process is complete, financial resources have been allocated and the customer has made a firm verbal commitment that the order is in the process of execution. Backlog at the beginning of any period is not necessarily indicative of future performance. Our presentation of backlog may differ from other companies in our industry.

Accounts payable decreased to $3,032,613 as of September 30, 2016 from $3,311,809 at December 31, 2015, using $279,196 in cash flow from operations. Accrued expenses increased to $1,189,669 as of September 30, 2016 from $1,066,860 as of December 31, 2015, providing $122,809 of cash from operations. The Company expects accounts payable and accrued expenses to fluctuate with routine changes in operations.

During the first nine months of 2016, our investing activities used $2,201,722 of cash and included purchases of property and equipment of $130,499, expenditures related to intangible assets of $71,223 and an investment of $2,000,000 in our joint venture.

During the first nine months of 2016, our financing activities included $150,000 in proceeds from the amendment of our convertible debt agreement, $312,698 in proceeds from the exercise of stock options, $2,700,000 in proceeds from the exercise of stock warrants, and the payment of expenses from the issuance of our common stock of $28,548. This includes the issuance of stock related to the acquisition of the noncontrolling interest in Ilios.

Table of Contents

TECOGEN INC.

Significant Accounting Policies and Critical Estimates

The Company’s significant accounting policies are discussed in the Notes to the Condensed Consolidated Financial Statements above and in our Annual Report. The accounting policies and estimates that can have a significant impact upon the operating results, financial position and footnote disclosures of the Company are described in the above notes and in our Annual Report.

Seasonality

We expect that the majority of our heating systems sales will be in the winter and the majority of our chilling systems sales will be in the summer. Our cogeneration and chiller system sales are not generally affected by the seasons, although customer goals will be to have chillers installed and running in the spring. Our service team does experience higher demand in the warmer months when cooling is required. These units are generally shut down in the winter and started up again in the spring. This “busy season” for the service team generally runs from May through the end of September.

Off-Balance Sheet Arrangements

Currently, we do not have any material off-balance sheet arrangements, including any outstanding derivative financial instruments, off-balance sheet guarantees, interest rate swap transactions or foreign currency contracts. We do not engage in trading activities involving non-exchange traded contracts.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Not applicable.

Item 4. Controls and Procedures.

Management’s Evaluation of Disclosure Controls and Procedures:

The Company maintains "disclosure controls and procedures,” as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, that are designed to provide reasonable assurance that information required to be disclosed by the Company in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to the Company's management, including our principal executive officers and principal financial and accounting officer, as appropriate, to allow timely decisions regarding required disclosure.

Our disclosure controls and procedures are designed to provide reasonable assurance that the control system’s objectives will be met. Our management, including our Co-Chief Executive Officers and Chief Financial Officer, after evaluating the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report, have concluded that our disclosure controls and procedures were not effective due to material weaknesses in financial reporting relating to lack of personnel with a sufficient level of accounting knowledge and a small number of employees dealing with general controls over information technology. Management will continue to evaluate the above weaknesses, and as the Company grows and resources become available, the Company plans to take the necessary steps in the future to remediate the weaknesses.

Changes in Internal Control over Financial Reporting:

The Company currently does not have personnel with a sufficient level of accounting experience and training in the selection, application and implementation of generally accepted accounting principles as it relates to complex transactions and financial reporting requirements. The Company also has a small number of employees dealing with general controls over information technology security and user access. This constitutes a material weakness in financial reporting.

In connection with the material weaknesses referred to in the foregoing paragraph, we will make changes in our internal controls over financial reporting as soon as the resources become available. During the period ended September 30, 2016, no changes have been made to the Company's process.

Table of Contents

TECOGEN INC.

PART II - OTHER INFORMATION

Item 6. Exhibits



Exhibit No.		Description of Exhibit
2.1		Agreement and Plan of Merger, dated November 1, 2016, among the Company, Tecogen, Inc. and Tecogen.ADGE Acquisition Corp.^(k)
3.1		Amended and Restated Certificate of Incorporation.^(a)
3.2		Amended and Restated Bylaws.^(a)
4.1		Specimen Stock Certificate of Tecogen, Inc. ^(a)
4.2		Form of Restricted Stock Purchase Agreement.^(b)
4.3		Form of Stock Option Agreement.^(a)
4.6		Tecogen Ultratek Warrant signed August 2, 2016.^(j)
10.8		Second Amendment to Lease between Atlantic-Waltham Investment II, LLC dated Jan 16, 2013.^(a)
10.19		Form of Common Stock Purchase Agreement. ^(a)
10.21		Senior Convertible Promissory Note, dated December 23, 2013, by Tecogen Inc. in favor of Michaelson Capital Special Finance Fund LP. ^(a)
10.26+		Tecogen 2006 Stock Incentive Plan, as amended on January 24, 2014 with stockholder approval on July 15, 2014.^(e)
10.27		Non-Revolving Line of Credit Agreement between the Company and John N. Hatsopoulos, dated June 15, 2015.^(e)
10.36		Amendment No. 1 to the Senior Convertible Promissory Note effective April 1, 2016.^(g)
10.37		Tedom Joint Venture Agreement dated May 19, 2016. ^(h)
10.38		Tedom Joint Venture LLC Agreement dated May 19, 2016. ^(h)
10.39		Form of a Warrant Amendment dated June 27, 2016.⁽ⁱ⁾
31.1*		Rule 13a-14(a) Certification of Co-Chief Executive Officer
31.2*		Rule 13a-14(a) Certification of Co-Chief Executive Officer
31.3*		Rule 13a-14(a) Certification of Chief Financial Officer
32.1*		Section 1350 Certifications of Co-Chief Executive Officers and Chief Financial Officer
101.INS**		XBRL Instance Document
101.SCH**		XBRL Taxonomy Extension Schema
100.CAL**		XBRL Taxonomy Extension Calculation Linkbase
100.DEF**		XBRL Taxonomy Extension Definition Linkbase
101.LAB**		XBRL Taxonomy Extension Label Linkbase
101.PRE**		XBRL Taxonomy Extension Presentation Linkbase

____________________________________________


*	Filed herewith


**	Furnished herewith


+	Compensatory plan or arrangement


^(a)	incorporated by reference from the Company's Registration Statement on Form S-1/A (Registration No. 333-193791), filed with the SEC on June 27, 2014.


^(b)	incorporated by reference from the Company's Registration Statement on Form S-1 (Registration No. 333-178697), originally filed with the SEC on December 22, 2011.


^(c)	incorporated by reference from the Company's 10-Q Report for the period ending June 30, 2014, originally filed with the SEC on August 14, 2014.


^(d)	incorporated by reference from the Company's form 8-K Report originally filed with the SEC on August 6, 2015.


^(e)	incorporated by reference from the Company's 10-Q Report for the period ending June 30, 2015, originally filed with the SEC on August 6, 2015.


^(f)	incorporated by reference from the Company's form 8-K Report originally filed with the SEC on August 13, 2015.


^(g)	incorporated by reference from the Company's form 8-K Reports originally filed with the SEC on April 15, 2016.


^(h)	incorporated by reference from the Company's form 8-K Reports originally filed with the SEC on May 24, 2016.


⁽ⁱ⁾	incorporated by reference from the Company's form 8-K Reports originally filed with the SEC on June 30, 2016.


^(j)	incorporated by reference from the Company's form 8-K Reports originally filed with the SEC on August 8, 2016.


^(k)	incorporated by reference from the Company's form 8-K Reports originally filed with the SEC on November 2, 2016.

Table of Contents

TECOGEN INC.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, on November 14, 2016.



	TECOGEN INC.
	(Registrant)

	By:	/s/ John N. Hatsopoulos
	Co-Chief Executive Officer
	(Principal Executive Officer)

	By:	/s/ Benjamin M. Locke
	Co-Chief Executive Officer
	(Principal Executive Officer)

	By:	/s/ David A. Garrison
	Chief Financial Officer, Treasurer and Secretary
	(Principal Financial and Accounting Officer)